Correlation and Traditional Chinese Medicine Intervention of Pyroptosis and Liver Diseases
10.13422/j.cnki.syfjx.20212123
- VernacularTitle:细胞焦亡与肝脏疾病的相关性及中医药研究进展
- Author:
Yong CHEN
1
;
Le QIN
1
;
Xiao-xue YE
2
;
Jing-jing WANG
1
;
Zhi-pin ZHOU
2
Author Information
1. Guangxi University of Chinese Medicine，Nanning 530200，China
2. Liuzhou People's Hospital Affiliated to Guangxi Medical University，Guangxi Key Laboratory of Clinical Disease Biotechnology，Guangxi Zhuang Autonomous Region Health Commission，Liuzhou 545006，China
- Publication Type:Research Article
- Keywords:
Chinese medicine;
liver diseases;
pyroptosis;
NOD-like receptor protein 3 （NLRP3） inflammasome
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2021;27(21):232-241
- CountryChina
- Language:Chinese
-
Abstract:
Pyroptosis， also known as cell inflammatory necrosis， is different from apoptosis， necrosis， and other forms of cell death in morphological characteristics， occurrence， and regulatory mechanism. It is a new type of programmed cell death dependent on Caspase， which has been discovered and confirmed in recent years. Studies have shown that pyroptosis is closely related to the occurrence of liver diseases， and is critical in alcoholic liver disease （ALD）， non-alcoholic fatty liver disease （NAFLD）， liver fibrosis， and liver cancer. Pyroptosis causes inflammatory injury of hepatocytes to promote the occurrence and development of liver diseases by activating Caspase-1， cleaving the effector gasdermin-D （GSDMD）， and releasing pro-inflammatory cytokines， such as interleukin-18 （IL-18） and interleukin-1β （IL-1β） mainly through the classical NOD-like receptor protein 3 （NLRP3） inflammasome pathway. Clinically， Chinese medicine in the treatment of liver diseases has unique efficacy and low side effects. In the intervention on liver diseases， Chinese medicine blocks the pyroptosis signaling pathway to relieve the liver inflammation by inhibiting the assembly and activation of NLRP3 inflammasome multiprotein complex， blunting the activity of Caspase-1 or Caspase-4/Caspase-5/Caspase-11， and inhibiting the cleavage of GSDMD to reduce the release of pro-inflammatory cytokines such as IL-18 and IL-1β. Therefore， in-depth investigation of pyroptosis facilitates unveiling its role in the occurrence， development， and prognosis of liver diseases， and the enhancement or inhibition of pyroptosis may provide a new strategy for the prevention and treatment of liver diseases by Chinese medicine. At present， NLRP3 inflammasome， a key protein in the classic pyroptosis signaling pathway， has become an anti-liver disease target of Chinese medicine. This study briefly summarized the relationship between pyroptosis and liver diseases and reviewed the intervention of monomers， compound prescriptions， effective fractions and extracts of Chinese medicine in recent years to provide important guidance for further exploring the pathogenic mechanism of pyroptosis and the treatment of liver diseases with Chinese medicine.
